epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Altavera
    levonorgestrel/ ethinyl estradiol
  • remove BAL In Oil
    dimercaprol
  • remove Mavyret
    glecaprevir/ pibrentasvir

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Altavera (levonorgestrel/ ethinyl estradiol) + Mavyret (glecaprevir/ pibrentasvir)

Avoid/Use Alternative


ethinyl estradiol (contraceptive) + glecaprevir

avoid combo if ethinyl estradiol dose >20 mcg/day: combo may incr. risk of ALT elevation (additive effects)

ethinyl estradiol (contraceptive) + pibrentasvir

avoid combo if ethinyl estradiol dose >20 mcg/day: combo may incr. risk of ALT elevation (additive effects)

Additional Considerations

Smiley face Smiley face pibrentasvir in Mavyret

caution advised with narrow therapeutic index drugs extensively metabolized in the liver; viral eradication may improve hepatic metabolic function, decr. levels, efficacy of concomitant drugs

monitor glucose with drugs used for diabetes tx; viral eradication may change hepatic function, alter blood glucose control resulting in serious symptomatic hypoglycemia

Smiley face Smiley face glecaprevir in Mavyret

caution advised w/ narrow therapeutic index drugs extensively metabolized in the liver; viral eradication may improve hepatic metabolic function, decr. levels, efficacy of concomitant drugs

monitor glucose w/ drugs used for diabetes tx; viral eradication may change hepatic function, alter blood glucose control resulting in serious symptomatic hypoglycemia

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information